A recent case has highlighted how a failure to identify an ovarian tumour during a routine scan allowed the disease to progress to a terminal stage. Sadly, this type of medical negligence can leave patients facing life-limiting illness, reduced treatment options, and devastating long-term consequences.
Early recognition of ovarian cancer is critical. When healthcare professionals miss or misinterpret warning signs, patients may lose the opportunity for effective treatment.
Ovarian cancer develops when cells in or around the ovaries undergo genetic mutations. These mutations cause the cells to grow and divide uncontrollably, forming a malignant tumour. Over time, untreated cancer can spread to other parts of the body, significantly reducing survival rates.
Several different forms of ovarian cancer exist, each with distinct characteristics and treatment approaches.
This is the most common type and begins in the cells covering the ovaries.
These rare tumours usually affect girls and younger women, often under the age of 30.
These tumours develop in the tissues that support the ovaries and produce hormones. They can be either benign or malignant.
Borderline tumours involve abnormal cells on the surface of the ovary. While often non-cancerous, they usually require surgical treatment.
Ovarian cancer is the sixth most common cancer affecting women in the UK. Each year, approximately 7,500 women receive a diagnosis, equating to around 21 new cases every day.
The condition primarily affects women over the age of 50. However, it can occur at any age and, in some cases, runs in families due to inherited genetic factors.
Symptoms of ovarian cancer can be subtle and non-specific, which often leads to delayed diagnosis. Nevertheless, persistent symptoms should never be ignored.
Common symptoms include:
Other symptoms may include:
Because many of these symptoms overlap with less serious conditions, clinicians must investigate them thoroughly when they persist or worsen.
Early diagnosis of ovarian cancer significantly improves treatment outcomes and survival rates. It also reduces the likelihood of the cancer spreading to other organs.
However, only around 20% of ovarian cancers are detected at stage 1. This low figure reflects the absence of a reliable screening programme and the vague nature of early symptoms.
Blood tests measuring CA125 levels can help identify potential ovarian cancer. However, raised CA125 levels are not always cancer-related and can occur in conditions such as endometriosis or fibroids. Crucially, abnormal results must be properly followed up to avoid missed diagnoses.
Treatment depends on several factors, including the cancer type, size, spread, and the patient’s overall health.
Common treatments include:
Patients usually receive ongoing monitoring during and after treatment, including follow-up appointments, scans, and blood tests to manage side effects and detect recurrence.
All women should remain aware of the symptoms of ovarian cancer, regardless of age. Prompt investigation of symptoms plays a vital role in achieving early diagnosis, enabling more effective treatment and improving survival chances.
When healthcare professionals fail to recognise symptoms or misinterpret test results, the consequences can be life-changing.
If you believe medical negligence contributed to a delayed or missed diagnosis of ovarian cancer, it is important to seek legal advice as soon as possible. Advanced ovarian cancer can significantly affect your quality of life, ability to work, and long-term wellbeing.
Specialist medical negligence solicitors can:
If you believe you have been affected by medical negligence, contact NJS Law for a free, no-obligation consultation. Our experienced medical negligence team is committed to supporting you through this challenging time and helping you pursue the compensation you deserve.
We are available by email or phone and are here to help every step of the way.
Get in touch using the form below or via the following methods:
